Form 4 for BOLT Bolt Biotherapeutics, Inc.
Accepted 2026-02-04 00:00:00 ET · period of report 2026-01-28 · accession 0001193125-26-037690 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-04 | 2025-12-05 | BOLT | Nemec Sarah | Senior VP, Fin, PAO | P - Purchase | $4.61 | +125 | 1,415 | +10% | +$576.25 |
| D | 2026-02-04 | 2026-01-28 | BOLT | Nemec Sarah | Senior VP, Fin, PAO | A - Grant | $0.00 | +8,000 | 8,000 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-05 | P | A | 125 | $4.61 | 1,415 | D | — | — | |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2026-01-28 | A | A | 8,000 | $0.00 | 8,000 | D | $6.71 · — to 2036-01-27 | 8,000 Common Stock | (F2) For so long as the Reporting Person continuously provides services to the Issuer this option will vest with respect to the shares as follows: 1/36th of the shares will vest upon the Reporting Person completing each month of continuous service following January 1, 2026. |